www.fdanews.com/articles/176648-bd-earns-ce-mark-for-vaginal-panel
Becton, Dickinson and Company has received a CE Mark for the BD Max Vaginal Panel, an in vivo test designed to detect microorganisms present in bacterial vaginosis, candidiasis and trichomoniasis.
The company’s BD Max platform combines PCR extraction, amplification and detection. — Anisa Jibrell